Condition
Prostate Cancer Metastatic Castration-Resistant clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Prostate Cancer Metastatic Castration-Resistant clinical trials that are recruiting, at sites in 3 countries (most in Canada (1), Germany (1), China (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Prostate Cancer Metastatic Castration-Resistant clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adaptive external beam radiotherapy added to Lutetium-177 PSMA therapy for metastatic castration-resistant prostate cancer | Phase 2 | Montreal, Quebec | Recruiting | Jan 21, 2026 |
| Sacituzumab tirumotecan plus tagitanlimab for aggressive and neuroendocrine prostate cancer | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Sep 18, 2025 |
| Blood-based tumor DNA testing during PSMA radioligand therapy | — | Augsburg and 2 other locations | Recruiting | Aug 12, 2025 |
All recruiting trials (3)
-
Adaptive external beam radiotherapy added to Lutetium-177 PSMA therapy for metastatic castration-resistant prostate cancer
This trial tests whether adding targeted external beam radiotherapy during Lutetium-177 PSMA treatment can improve outcomes for men with metastatic castration‑resistant prostate cancer.
-
Sacituzumab tirumotecan plus tagitanlimab for aggressive and neuroendocrine prostate cancer
This trial tests whether combining sacituzumab tirumotecan with the immunotherapy tagitanlimab helps people with aggressive variant or neuroendocrine prostate cancer that has progressed after newer hormonal treatments.
-
Blood-based tumor DNA testing during PSMA radioligand therapy
This project will test whether blood-based liquid biopsies taken before, during, and after PSMA radioligand therapy can help predict outcomes for men with metastatic castration-resistant prostate cancer.
Related topics
Quick answers
How many Prostate Cancer Metastatic Castration-Resistant clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Canada (1 trial), Germany (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.